bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Influenza
Immunization
Viruses
 Resources from HONselect
Slimy Frog Might Be a Flu Fighter
Study found sticky coating shielded mice against H1 strain, could lead to new antiviral treatments

By Robert Preidt

TUESDAY, April 18, 2017 (HealthDay News) -- It sounds like weird science, but the slime that coats the skin of South Indian frogs might fight some strains of the flu.

A new mouse study suggests this is so, although research in animals frequently doesn't pan out in humans.

What the researchers found was that certain peptides in the frogs' skin mucus can destroy the H1 variety of influenza viruses.

It was known that frogs' skin can secrete peptides that protect against bacteria. Peptides are short chains of amino acids, the building blocks of proteins. The new findings suggest these peptides could help lead to new antiviral treatments as well, the researchers said.

Such drugs could prove important when vaccines aren't available to deal with new strains of pandemic flu, or when known flu strains develop resistance to current medications, said study senior author Joshy Jacob.

One of the peptides in the frogs' skin mucus is called urumin. It protected unvaccinated mice against a lethal dose of H1 strains of flu, such as the 2009 pandemic strain. However, it was not effective against other current flu strains such as H3N2, the investigators found.

The study was published April 18 in the journal Immunity.

The researchers said they're now trying to find ways to stabilize antiviral peptides such as urumin, and to identify other frog-derived peptides that can protect against other viruses, such as mosquito-borne dengue and Zika.

Jacob is an associate professor of microbiology and immunology at the Emory Vaccine Center in Atlanta. He made his comments in an Emory University news release.

More information

The U.S. Centers for Disease Control and Prevention has more on influenza.

SOURCE: Emory University, news release, April 18, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=721601

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Peptides
Sprains and Strains
Research Personnel
Lead
Therapeutics
Mucus
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact